S&CO Inc. Makes New $895,000 Investment in HCA Healthcare, Inc. $HCA

S&CO Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,298 shares of the company’s stock, valued at approximately $895,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. lifted its position in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the period. MJP Associates Inc. ADV raised its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC raised its position in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its position in shares of HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Truist Financial decreased their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Argus reduced their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Barclays decreased their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. Finally, Morgan Stanley dropped their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $465.59.

HCA Healthcare Price Performance

Shares of HCA stock opened at $404.61 on Friday. The stock has a market cap of $87.60 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10. The company has a fifty day moving average price of $393.41 and a two-hundred day moving average price of $446.80. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the previous year, the firm earned $6.84 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.45%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.